Clinical trial
A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and…
NCT00411307 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00411307 |
|---|---|
| Title | A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain |
| Official title | A Randomized, Open-Label, Single-Dose, Pilot Study to Evaluate the Safety and Efficacy of OROS Hydromorphone in Patients With Acute, Moderate-to-Severe Postoperative Pain |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Postoperative, Orthopedic Procedures, Analgesia |
| Intervention type | Drug |
| Interventions | OROS hydromorphone HCI |
| Enrollment | 50 |
| Completion | Oct 1, 2001 |
| First posted | Dec 14, 2006 |
| Last update posted | Apr 27, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: